Cytodyn Inc (CYDY)

[$5.95akadawson-m]

This is such an important piece of today's PR. Is Lalezari speculating? CytoDyn would not be releasing a PR without being damn certain that Leronlimab can effectuate this incredible result. And coupled with the new president, the share price can only go up from here.

“The potential for a one-time gene therapy encoding a protein such as leronlimab represents a great hope for the future of HIV therapy and functional cure. Currently, cells deficient in CCR5 have demonstrated a potential path to HIV cure, and bone marrow transplant is not an option for most patients because it is risky and highly invasive. We look forward to exploring this critical area with the assistance of the NIH and advancing research with hopes of finding a functional cure and helping to end the HIV pandemic.”